Article

Drug REpurposing using AI/ML tools - for Rare Diseases (DREAM-RD): A case study with Fragile X Syndrome (FXS)

2020-09-28

Abstract excerpt

Drug repositioning is emerging as an increasingly relevant option for rare disease therapy and management. Various methods for identifying suitable drug candidates have been tried and range from clinical symptomatic repurposing to data driven strategies which are based on the disease-specific gene or protein expression, modification, signalling and physiological perturbation profiles. The use of Artificial Intelli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6fc2d333-d09b-534a-af2a-522f530d7bfb
DOI: 10.1101/2020.09.25.311142

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug REpurposing using AI/ML tools - for Rare Diseases (DREAM-RD): A case study with Fragile X Syndrome (FXS)DOI 10.1101/2020.09.25.311142Read

Integrative Omics for Informed Drug Repurposing: Targeting CNS DisordersSemantic proximity Read

From genomics to clinic: the transformative impact of AI in pharmacogenomics and personalized medicine.Semantic proximity Read

Artificial intelligence-assisted phenotype discovery of fragile X syndrome in a population-based sample.Semantic proximity Read

Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic dataSemantic proximity Read

Prediction of drug targets for specific diseases leveraging gene perturbation data: A machine learning approachSemantic proximity Read

Machine Learning Identifies Novel Candidates for Drug Repurposing in Alzheimer’s DiseaseSemantic proximity Read

Drug Repurposing in Rare Diseases: An Integrative Study of Drug Screening and Transcriptomic Analysis in Nephropathic CystinosisSemantic proximity Read

AI and Precision Medicine: Paving the Way for Future TreatmentSemantic proximity Read

Integrating Artificial Intelligence with Genomic and Biomarker Data for the Advancement of Personalized Therapeutics in a Human-Centric FrameworkSemantic proximity Read

Using genome-wide association results to identify drug repurposing candidatesSemantic proximity Read

A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene ExpressionSemantic proximity Read

The Drug Repurposing Encyclopedia (DRE): a web server for systematic drug repurposing across 20 organismsSemantic proximity Read